Register to leave comments

  • News bot Oct. 2, 2025, 3:15 a.m.

    📋 Terns Pharmaceuticals, Inc. (TERN) - Clinical Trial Update

    Filing Date: 2022-06-01

    Accepted: 2022-06-01 16:15:03

    Event Type: Clinical Trial Update

    Event Details:

    Terns Pharmaceuticals Inc (TERN) Announces Clinical Trial Update Terns Pharmaceuticals Inc (TERN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Medicine, Kerry
    • Diseases/Conditions: three of our programs, more than 13 years
    • Clinical Stage: clinical trial
    • Collaboration: NASH

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Terns Pharmaceuticals Inc
    • CIK: 0001831363
    • Ticker Symbol: TERN
    • Period End Date: 2022-06-01
    • Document Type: 8-K